Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 136.42 Delayed Data As of 4:00pm ET |  +4.20 / +3.18%Today’s Change | 78.26 Today|||52-Week Range 219.75 | +37.17% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Higgins John L Chief Executive Officer |  Sale | 2/05/2021 | 54,666 | $203.40 | $11.1M | -32.87% |
Higgins John L Chief Executive Officer | Sale | 1/25/2021 | 50,000 | $159.00 | $8.0M | -12.64% |
Foehr Matthew William President & Chief Operating Officer | Sale | 2/04/2021 | 44,547 | $176.86 | $7.9M | -24.33% |
Higgins John L Chief Executive Officer | Sale | 1/27/2021 | 40,000 | $182.00 | $7.3M | -16.36% |
Berkman Charles Stuart /vernalis/ General Counsel & Senior Vice President | Sale | 2/04/2021 | 18,097 | $178.50 | $3.2M | -24.33% |
Sabba Stephen L Director | Sale | 2/09/2021 | 14,114 | $208.55 | $2.9M | -36.85% |
Davis Todd C Director | Sale | 2/10/2021 | 5,083 | $213.14 | $1.1M | -35.36% |
Foehr Matthew William President & Chief Operating Officer |  Buy | 2/04/2021 | 44,547 | $21.92 | $976.5K | -24.33% |
Higgins John L Chief Executive Officer | Buy | 2/05/2021 | 54,666 | $14.47 | $791.0K | -32.87% |
Higgins John L Chief Executive Officer | Buy | 1/25/2021 | 50,000 | $14.47 | $723.5K | -12.64% |
Page of 8